Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL623453 | 0.84 | ALDH1A1 (0.33) | ALDH1A1GAAKDM4EMEN1KMT2A | |
| SCHEMBL278738 | 0.76 | BBOX1 (0.33) | BBOX1 | |
| SCHEMBL3823555 | 0.74 | CA2 (0.45) | — | |
| SCHEMBL7718260 | 0.74 | CA2 (0.45) | — | |
| SCHEMBL3827255 | 0.74 | CA2 (0.45) | — | |
| SCHEMBL278213 | 0.73 | TSHR (0.36) | NPSR1BBOX1 | |
| Acrylamide SCHEMBL2879989 | 0.72 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL724271 | 0.71 | ALDH1A1 (0.36) | ALDH1A1GAAKDM4EMEN1KMT2A | |
| SCHEMBL254215 | 0.71 | ALPL (0.35) | ALDH1A1GAAKDM4EMEN1KMT2A | |
| SCHEMBL7132370 | 0.69 | BBOX1 (0.36) | ALDH1A1GAAKDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2266532-B1 | Composite particles, method for preparing the same and cosmetic compositon | SHINETSU CHEMICAL CO (JP) | 2017-09-06 | — | — | EP | disclosed |
| US-9205031-B2 | Composite particles, method for preparing the same and cosmetic composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2015-12-08 | — | — | US | disclosed |
| WO-2015106929-A1 | OIL-IN-WATER SILICONE EMULSION COMPOSITION | WACKER CHEMIE AG (DE) | 2015-07-23 | — | — | WO | disclosed |
| US-20100330132-A1 | COMPOSITE PARTICLES, METHOD FOR PREPARING THE SAME AND COSMETIC COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2010-12-30 | — | — | US | disclosed |
| EP-2266532-A2 | Composite particles, method for preparing the same and cosmetic compositon | Shin-Etsu Chemical Co., Ltd. (JP) | 2010-12-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100330132-A1 | COMPOSITE PARTICLES, METHOD FOR PREPARING THE SAME AND COSMETIC COMPOSITION | CUTA, AUP1, PLIN5 | ALDH1A1 2059/4885GAA 2350/4885KDM4E 3158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.